logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 12558343 B1

PDFFull Text
Date of Patent:
Feb. 24, 2026

Filed:

Mar. 09, 2021

Medical use of icaritin

Applicant:

Lunan Pharmaceutical Group Corporation, Linyi, CN;

Inventors:

Guimin Zhang, Linyi, CN;

Jingchun Yao, Linyi, CN;

Chenghong Sun, Linyi, CN;

Bin Li, Linyi, CN;

Sina Pan, Linyi, CN;

Assignee:

Lunan Pharmaceutical Group Corporation, Linyi, CN;

Attorneys:

McCarter & English, LLP

Yu Lu

Primary Examiner:

Sarah Pihonak

Assistant Examiner:

Padmaja S Rao

Int. Cl.
CPC ...
A61P 7/04 (2006.01); A61K 9/00 (2006.01); A61K 9/107 (2006.01); A61K 9/20 (2006.01); A61K 9/48 (2006.01); A61K 31/352 (2006.01); A61K 31/4365 (2006.01); A61K 31/616 (2006.01); A61K 31/727 (2006.01); A61K 38/48 (2006.01); A61K 38/49 (2006.01); A61K 47/10 (2017.01); A61K 47/26 (2006.01); A61K 47/44 (2017.01); A61P 1/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/352 (2013.01); A61K 9/0019 (2013.01); A61K 9/1075 (2013.01); A61K 9/2018 (2013.01); A61K 9/2031 (2013.01); A61K 9/2054 (2013.01); A61K 9/4825 (2013.01); A61K 9/4858 (2013.01); A61K 9/4866 (2013.01); A61K 9/4875 (2013.01); A61K 9/4891 (2013.01); A61K 31/4365 (2013.01); A61K 31/616 (2013.01); A61K 31/727 (2013.01); A61K 38/48 (2013.01); A61K 38/482 (2013.01); A61K 38/49 (2013.01); A61K 47/10 (2013.01); A61K 47/26 (2013.01); A61K 47/44 (2013.01); A61P 1/00 (2018.01); A61P 7/04 (2018.01); C12Y 304/00 (2013.01); C12Y 304/21031 (2013.01); C12Y 304/21068 (2013.01);
Abstract

The present disclosure provides use of icaritin in preparing a drug for preventing and treating a bleeding disorder and belongs to the field of medicine. The icaritin can relieve platelet dysfunction, shorten thromboplastin time, and promote blood coagulation, and can be used for preventing and treating the bleeding disorder, especially for treating hemorrhagic transformation after cerebral infarction, gastrointestinal bleeding caused by a thrombolytic or antithrombotic drug for cerebral infarction, or a bleeding complication of a thrombolytic or antithrombotic drug for myocardial infarction.

Find Patent Forward Citations

Loading…